FNY Investment Advisers’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $74K | Sell |
1,610
-1,500
| -48% | -$68.9K | 0.03% | 332 |
|
2025
Q1 | $189K | Sell |
3,110
-9,320
| -75% | -$566K | 0.12% | 148 |
|
2024
Q4 | $703K | Buy |
12,430
+12,360
| +17,657% | +$699K | 0.36% | 63 |
|
2024
Q3 | $3K | Hold |
70
| – | – | ﹤0.01% | 550 |
|
2024
Q2 | $2K | Hold |
70
| – | – | ﹤0.01% | 367 |
|
2024
Q1 | $3 | Sell |
70
-5,780
| -99% | -$248 | ﹤0.01% | 526 |
|
2023
Q4 | $300K | Buy |
5,850
+5,780
| +8,257% | +$296K | 0.33% | 64 |
|
2023
Q3 | $4K | Buy |
70
+20
| +40% | +$1.14K | ﹤0.01% | 448 |
|
2023
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 392 |
|
2023
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 413 |
|
2022
Q4 | $3K | Buy |
+50
| New | +$3K | ﹤0.01% | 364 |
|
2022
Q3 | – | Sell |
-35
| Closed | -$2K | – | 619 |
|
2022
Q2 | $2K | Buy |
+35
| New | +$2K | ﹤0.01% | 521 |
|
2022
Q1 | – | Sell |
-70
| Closed | -$4K | – | 684 |
|
2021
Q4 | $4K | Sell |
70
-22,500
| -100% | -$1.29M | ﹤0.01% | 403 |
|
2021
Q3 | $1.34M | Buy |
+22,570
| New | +$1.34M | 0.62% | 44 |
|
2021
Q1 | – | Sell |
-15,000
| Closed | -$930K | – | 743 |
|
2020
Q4 | $930K | Buy |
15,000
+12,500
| +500% | +$775K | 0.25% | 97 |
|
2020
Q3 | $150K | Buy |
+2,500
| New | +$150K | 0.06% | 185 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 380 |
|
2020
Q1 | – | Hold |
0
| – | – | – | 433 |
|
2019
Q4 | – | Hold |
0
| – | – | – | 757 |
|
2019
Q2 | – | Hold |
0
| – | – | – | 888 |
|
2019
Q1 | – | Hold |
0
| – | – | – | 650 |
|
2018
Q3 | – | Hold |
0
| – | – | – | 763 |
|
2018
Q2 | – | Hold |
0
| – | – | – | 893 |
|